ÁcrataMagallania
Madmaxista
- Desde
- 10 Jul 2014
- Mensajes
- 18.253
- Reputación
- 86.873
Por recapitular sobre la banderilla de Pfizer, de lo poco que han dejado que se sepa.
Esto que pego es del comunicado del gobierno británico para el NHS.
Un día después, resulta que el personal sanitario no será de los primeros en ponérsela, como estaba planeado.
4.6 Fertility, pregnancy and lactation
Pregnancy
There are no or limited amount of data from the use of el bichito-19 mRNA Vaccine BNT162b2.
Animal reproductive toxicity studies have not been completed. el bichito-19 mRNA Vaccine
BNT162b2 is not recommended during pregnancy.
For women of childbearing age, pregnancy should be excluded before vaccination. In addition, women of childbearing age should be advised to avoid pregnancy for at least 2 months after their second dose.
Breast-feeding
It is unknown whether el bichito-19 mRNA Vaccine BNT162b2 is excreted in human milk. A risk to
the newborns/infants cannot be excluded. el bichito-19 mRNA Vaccine BNT162b2 should not be used during breast-feeding.
Fertility
It is unknown whether el bichito-19 mRNA Vaccine BNT162b2 has an impact on fertility.
(Sencillamente flipante)
Incide en esto al final:
5.3 Preclinical safety data
Non-clinical data reveal no special hazard for humans based on a conventional study of repeat dose toxicity. Animal studies into potential toxicity to reproduction and development have not been completed.
(supongo, aunque no lo sé, que si no han acabado dichos estudios en animales no los han empezado en humanos, o no tendría sentido no haberse saltado ese paso si hubieran podido)
Bastante más abajo del documento, una curiosidad:
...among the participants who received el bichito-19 mRNA vaccine, 51.1% were male
and 48.9% were female, 82.8% were White, 8.9% were Black or African American, 26.8% were
Hispanic/Latino, 4.5% were Asian and 0.6% were Native American/Alaskan native. 57.2% were aged 16-55 years, 42.6% were aged > 55 years and 21.8% were ≥ 65 years.
(United States, Europe, Turkey, South Africa and
South America)
Esto que pego es del comunicado del gobierno británico para el NHS.
Un día después, resulta que el personal sanitario no será de los primeros en ponérsela, como estaba planeado.
4.6 Fertility, pregnancy and lactation
Pregnancy
There are no or limited amount of data from the use of el bichito-19 mRNA Vaccine BNT162b2.
Animal reproductive toxicity studies have not been completed. el bichito-19 mRNA Vaccine
BNT162b2 is not recommended during pregnancy.
For women of childbearing age, pregnancy should be excluded before vaccination. In addition, women of childbearing age should be advised to avoid pregnancy for at least 2 months after their second dose.
Breast-feeding
It is unknown whether el bichito-19 mRNA Vaccine BNT162b2 is excreted in human milk. A risk to
the newborns/infants cannot be excluded. el bichito-19 mRNA Vaccine BNT162b2 should not be used during breast-feeding.
Fertility
It is unknown whether el bichito-19 mRNA Vaccine BNT162b2 has an impact on fertility.
(Sencillamente flipante)
Incide en esto al final:
5.3 Preclinical safety data
Non-clinical data reveal no special hazard for humans based on a conventional study of repeat dose toxicity. Animal studies into potential toxicity to reproduction and development have not been completed.
(supongo, aunque no lo sé, que si no han acabado dichos estudios en animales no los han empezado en humanos, o no tendría sentido no haberse saltado ese paso si hubieran podido)
Bastante más abajo del documento, una curiosidad:
...among the participants who received el bichito-19 mRNA vaccine, 51.1% were male
and 48.9% were female, 82.8% were White, 8.9% were Black or African American, 26.8% were
Hispanic/Latino, 4.5% were Asian and 0.6% were Native American/Alaskan native. 57.2% were aged 16-55 years, 42.6% were aged > 55 years and 21.8% were ≥ 65 years.
(United States, Europe, Turkey, South Africa and
South America)